Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2018-05-23 AGM Information
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
DiaSorin S.p.A.-Verbale Assemblea degli Azionisti 23 aprile 2018
AGM Information Classification · 100% confidence The document text is titled "VERBALE DELL'ASSEMBLEA ORDINARIA DEL 23APRILE 2018" (Minutes of the Ordinary General Meeting of April 23, 2018). It details the proceedings, attendees, quorum, agenda items (including approval of the 2017 financial statements, distribution of dividends, remuneration report, and stock options plan), discussions, and voting results of a formal shareholder meeting. This content directly corresponds to the documentation generated during or immediately following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2018-05-23 Italian
Shareholders' Meeting April 23, 2018 - Explanatory reports and motion for resolutions
AGM Information Classification · 100% confidence The document explicitly announces a 'SHAREHOLDERS' MEETING' for DiaSorin S.p.A. on April 23/24, 2018. It contains 'EXPLANATORY REPORTS AND MOTIONS FOR RESOLUTIONS CONCERNING THE ITEMS ON THE AGENDA'. The agenda items include approval of financial statements, distribution of dividends, compensation report, stock option plan, and treasury share transactions. This content is characteristic of the preparatory materials distributed to shareholders ahead of an Annual General Meeting (AGM) to inform their votes. While it contains financial report information (Item 1), the primary purpose and structure align with the materials provided for the AGM itself, which is best classified as AGM Information (AGM-R). It is not the final 10-K, nor is it just a proxy statement (DEF 14A/PSI), as it contains the explanatory reports for all resolutions, including governance and financial matters.
2018-04-16 English
DiaSorin S.p.A.-Annual Financial Report 2017
Annual Report Classification · 100% confidence The document is titled 'ANNUAL FINANCIAL REPORT DECEMBER 31, 2017' and contains a comprehensive table of contents covering the report on operations, consolidated financial statements, independent auditors' report, and governance disclosures. It is a full-length annual report for the fiscal year ending December 31, 2017, which fits the definition of a 10-K (Annual Report). FY 2017
2018-04-16 Italian
DiaSorin S.p.A.-Compensation Report 2017
Remuneration Information Classification · 99% confidence The document is explicitly titled "COMPENSATION REPORT OF DIASORIN S.p.A Reporting year 2017" and repeatedly references preparation pursuant to Article 123-ter of the TUF and Article 84-quater of the Issuers' Regulations. This content directly relates to the remuneration and compensation structure for directors and executives. This aligns perfectly with the definition for Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors. The document is a full report, not an announcement of a report.
2018-03-30 Italian
DiaSorin S.p.A.-Relazione sulla Remunerazione Esercizio 2017
Remuneration Information Classification · 99% confidence The document title is "RELAZIONE SULLA REMUNERAZIONE DELLA DIASORIN S.p.A. Esercizio 2017" (Remuneration Report of Diasorin S.p.A. Fiscal Year 2017). It explicitly states it is prepared pursuant to Article 123-ter of the TUF (Italian Consolidated Financial Act) and Article 84-quater of the Issuers' Regulation. This content directly corresponds to the definition of a Remuneration Report, which in the provided schema maps to 'Remuneration Information' (Code: DEF 14A), as this code is used for reports detailing compensation for top executives and directors, analogous to the US DEF 14A filing which covers executive compensation.
2018-03-30 Italian
DiaSorin S.p.A.-Relazione Finanziaria Annuale Esercizio 2017
Annual Report Classification · 100% confidence The document is titled 'RELAZIONE FINANZIARIA ANNUALE AL 31 DICEMBRE 2017' (Annual Financial Report as of December 31, 2017). It contains a comprehensive table of contents including the management report, consolidated financial statements, audit reports, and corporate governance information for the full fiscal year. It is clearly the primary annual reporting document for DiaSorin S.p.A., fitting the definition of a 10-K (Annual Report). FY 2017
2018-03-30 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.